Stay updated with breaking news from Astrazeneca Evusheld. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new phase of the country’s COVID-19 response, easing pandemic restrictions, is once again drawing attention to those most vulnerable to the coronavirus as states and the Biden administration adopt more relaxed, endemic-focused guidelines.
It's been one year since President Biden signed the $1.9-trillion American Rescue Plan, and it's getting mixed reviews.
A private hospital system in Việt Nam said on Thursday they are set to soon use AstraZeneca's Evusheld, a long-acting antibody combination (tixagevimab co-packaged with cilgavimab), for the prevention of COVID-19 for the most at-risk groups of the population.
HANOI (Vietnam News/Asia News Network): A private hospital system in Vietnam said on Thursday (March 10) they are set to soon use AstraZeneca's Evusheld, a long-acting antibody combination (tixagevimab co-packaged with cilgavimab), for the prevention of Covid-19 for the most at-risk groups of the population.
There’s plenty of a new preventive COVID-19 treatment, Evusheld, in Utah for people who are immunocompromised or can’t be vaccinated against the virus for medical reasons. The Utah Department of Health reports there are thousands of doses already in Utah and more on the way.